免费国产一级A一片,热久久精品全部,亚洲中文字幕日韩,天天综合网久久网亚洲

全球一體化對人類健康提出了前所未有的挑戰(zhàn)，迫切需要培養(yǎng)和造就具國際水平和綜合能力的新一代領(lǐng)軍人才,針對關(guān)鍵的瓶頸問題，開展創(chuàng)新研究、改革創(chuàng)新體制，全面提升創(chuàng)新能力。生命醫(yī)學(xué)領(lǐng)域的創(chuàng)新發(fā)展，臨床研究和監(jiān)管審批是重要環(huán)節(jié)，共同肩負著對候選藥物、疫苗及醫(yī)療器械安全性和有效性的科學(xué)評估，是龐大和復(fù)雜的系統(tǒng)工程，是推動創(chuàng)新成果轉(zhuǎn)化的根本保障。為此，清華大學(xué)醫(yī)學(xué)院與葛蘭素史克合作，共同培養(yǎng)清華大學(xué)“臨床研究”與“監(jiān)管科學(xué)”博士后。希望有志的學(xué)生們踴躍報名，開拓視野，提高能力，展示才華，為“健康中國”和世界人民的健康福祉做突出貢獻。博士后研究目標和遴選要求如下：

1.臨床研究博士后項目

1.1培養(yǎng)目標：臨床研究博士后項目著重培養(yǎng)醫(yī)學(xué)畢業(yè)生的新藥及疫苗設(shè)計與研發(fā)能力，深入?yún)⑴cgsk在藥物及疫苗的臨床試驗項目以及臨床研究支持性功能的相關(guān)工作，熟練掌握藥物分析中生物統(tǒng)計學(xué)的應(yīng)用，藥代動力學(xué)評估的原理及方法等。

1.2職位要求：

·獲藥學(xué)，醫(yī)學(xué)，公共衛(wèi)生，或理學(xué)博士學(xué)位

·熟練掌握英語

·符合清華大學(xué)博士后入站要求

1.3培養(yǎng)領(lǐng)域

·傳染病、呼吸、腫瘤、免疫、疫苗領(lǐng)域的臨床試驗項目

·臨床實驗項目的運營、數(shù)據(jù)收集與管理、建模與模擬

1.4培養(yǎng)活動

·協(xié)助gsk臨床科學(xué)家的新藥及疫苗在研項目

·在gsk的不同部門進行輪轉(zhuǎn)，了解新藥及疫苗研發(fā)的整體流程

·學(xué)習(xí)藥物動力學(xué)以及生物統(tǒng)計學(xué)等在臨床評估中的應(yīng)用方法

·豐富的學(xué)術(shù)討論與交流活動

1.4培養(yǎng)目標：

·了解臨床研究在新藥及疫苗研發(fā)中的重要性

·掌握臨床數(shù)據(jù)分析的原理與方法

·熟悉藥物及疫苗分析的先進技術(shù)與局限性

·理解特殊群體臨床試驗中應(yīng)設(shè)計的要素

·完成項目總結(jié)報告

2.監(jiān)管科學(xué)博士后項目

2.1.培養(yǎng)目標：監(jiān)管科學(xué)博士后將與gsk的藥品監(jiān)管部門以及傳染病與公共健康研究中心的工作人員一起為gsk的臨床新藥及疫苗項目提供監(jiān)管科學(xué)支持。

2.2職位要求：

·獲藥學(xué)，醫(yī)學(xué)，公共衛(wèi)生，或理學(xué)博士學(xué)位

·熟練掌握英語

·符合清華大學(xué)博士后入站要求

2.3培養(yǎng)活動：

·了解中國藥品及疫苗審批指導(dǎo)原則與政策

·掌握藥品及疫苗研發(fā)與評估的原理及應(yīng)用

·熟悉藥品及疫苗ind，nda申請的要求與方法

·研究監(jiān)管政策的發(fā)展，應(yīng)用，以及指導(dǎo)原則的解析

申請方式：

應(yīng)聘者請將個人中英文簡歷及相關(guān)材料發(fā)送至zhangqi2013@mail.tsinghua.edu.cn。郵件主題請注明應(yīng)聘清華大學(xué)“臨床研究”與“監(jiān)管科學(xué)”博士后 ，簡歷文件名稱請包含姓名。申請截止日期2022年10月21日。

gsk-tsinghua postdoctoral fellowship program for clinical development and regulatory science

tsinghua university school of medicine, in collaboration with glaxosmithkline, is recruiting postdoctoral students to train for clinical development and research and regulatory science. the objectives and recruiting criteria are as following:

track 1: clinical development and research

fellows will participate in gsk’s current clinical development studies and trials in the areas of respiratory, immunology, infectious disease and hepatology, oncology, and vaccine, and support operational functions, e.g., clinical pharmacology modelling & simulation, data management, and operation and portfolio management. at the program, fellows will have hands-on training under the close supervision of gsk staff. the overall objective of the program is to provide post-graduate practical training or equivalent in the principles and applications of pharmaceutical and vaccine product development and evaluation; research design and methodology, including development of research protocols in the clinical investigation of new drugs and vaccines; and principles and applications of biostatistics, advanced pharmacokinetics, laboratory drug analysis, and study design methodology.

requirements:

doctorate in pharmacy, medicine, public health, or science.

professional proficiency in english and chinese.

meet the postdoctoral entry requirements of tsinghua university.

track 2: regulatory fellowship

the fellows will work with members of the gsk china regulatory affairs team and gsk’s institute for infectious diseases and public health to support ongoing clinical development portfolios under gsk china development. this program aims to enhance the knowledge and provide real-world experience of the fellow that helps to cultivate professionals of regulatory science ready for working in the pharmaceutical industry or academia .

selection criteria:

fellows will be selected based on their education background, relevant experience, and career goals as well as rules and regulations set forth by the tsinghua university for postdoctoral fellows.

a post graduate degree in pharmd, md, public health, or phd.

professional proficiency in english and chinese are required.

how to apply:

candidates are requested to send their resumes and related materials to zhangqi2013@mail.tsinghua.edu.cn.please indicate in the subject of the email to apply for tsinghua university "clinical research" and "regulatory science" postdoctoral program.

application deadline: oct 21, 2022.

信息來源于網(wǎng)絡(luò)，如有變更請以原發(fā)布者為準。

來源鏈接：

https://www.med.tsinghua.edu.cn/info/1374/4080.htm

101